Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study

Hemodialysis International

Volumn 11, Issue 3, 2007, Pages 340-348

  Kimata, Naoki ^a   Albert, Justin M ^b   Akiba, Takashi ^a   Yamazaki, Shin ^c   Kawaguchi, Yoshindo ^d   Fukuhara, Shunichi ^e   Akizawa, Tadao ^f   Saito, Akira ^g   Asano, Yasushi ^h   Kurokawa, Kiyoshi ⁱ   Pisoni, Ronald L ^b   Port, Friedrich K ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^c NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOKAI UNIVERSITY   (Japan)

^h Sashima Redcross Hospital   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

Author keywords

All cause mortality; Cardiovascular mortality; Hemodialysis patients; Japan Dialysis Outcomes and Practice Patterns Study (J DOPPS); Mineral metabolism

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEART DEATH; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MINERAL METABOLISM; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PREDICTION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CALCIUM; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MINERALS; PARATHYROID HORMONE; PHOSPHORUS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN;

EID: 34250742377     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2007.00190.x     Document Type: Article

References (16)

1. Block G, Port FK. Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial. 2003; 16:140-147.
2. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000; 87:E10-E17.
3. Chen NX, O'Neill KD, Duan D, Moe SM. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002; 62:1724-1731.
4. Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int. 2004; 66:2293-2299.
5. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis. 1998; 31:601-617.
6. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15: 2208-2218.
7. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001; 12:2131-2138.
8. Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005; 67: 1179-1187.
9. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342:1478-1483.
10. Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002; 39:695-701.
11. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002; 62:245-252.
12. Young EW, Goodkin DA, Mapes DL, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study. Kidney Int. 2000; 57(Suppl 74):S74-S81.
13. Goodkin DA, Mapes DL, Held PJ. The dialysis outcomes and practice patterns study (DOPPS): How can we improve the care of hemodialysis patients? Semin Dial. 2001; 14:157-159.
14. K/DOQI Guidelines. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 41 (Suppl 4): S1-201. Available From: http://www2.ajkd.org/scripts/om.dll/serve?web=/ajkd/ kdoqi.html&id=ajkd. Accessed February 20, 2004.
15. Block GA, Martin KJ, de Francisco ALM, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004; 350:1516-1525.
16. Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003; 14:3270-3277.